Digital Look

Welcome to Digital Look++,
you are not logged in

Mannkind Corp. (MNKD)

$ 5.62

AFRESA(R) Phase 3 Pulmonary Function Safety Data...	06-Jun-2009	PR Newswire
Studies Show AFRESA(R) Controls Post-Meal Sugar ...	06-Jun-2009	PR Newswire
MannKind Corporation to Hold First Quarter Finan...	27-Apr-2009	PR Newswire
MannKind Submits NDA for AFRESA for Treatment of...	16-Mar-2009	PR Newswire
MannKind Updates Status of NDA Submission for AF...	27-Feb-2009	PR Newswire
MannKind Corporation Reports Fourth Quarter and ...	17-Feb-2009	PR Newswire
MannKind Corporation to Hold Fourth Quarter Fina...	11-Feb-2009	PR Newswire
MannKind to Present at the 11th Annual Biotechno...	02-Feb-2009	PR Newswire
MannKind Reports Successful Completion of Device...	13-Jan-2009	PR Newswire
MannKind to Present at the 27th Annual J.P. Morg...	19-Dec-2008	PR Newswire
MannKind Reports Top-Line Results from Two Pivot...	18-Dec-2008	PR Newswire
MannKind Corporation to Review Positive Results ...	16-Dec-2008	PR Newswire
MannKind Reports Positive Results from Final Two...	04-Dec-2008	PR Newswire
MannKind to Present at the Piper Jaffray 20th An...	25-Nov-2008	PR Newswire
MannKind Corporation Reports Third Quarter Finan...	05-Nov-2008	PR Newswire
MannKind to Present at the Rodman & Renshaw ...	03-Nov-2008	PR Newswire
MannKind Corporation to Hold Third Quarter Finan...	29-Oct-2008	PR Newswire
MannKind Unveils Proposed Trade Name at Dedicati...	17-Sep-2008	PR Newswire
MannKind Reports Positive Data from a Phase 3 Cl...	16-Sep-2008	PR Newswire
MannKind to Present at the UBS Global Life Scien...	15-Sep-2008	PR Newswire

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.